Raewyn M. Poole

Mairangi Bay, AUK 0754, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Pembrolizumab: first global approval.

Pembrolizumab: first global approval.

Journal: Drugs

Published: October 22, 2014

Eliglustat: first global approval.

Eliglustat: first global approval.

Journal: Drugs

Published: September 21, 2014

Belinostat: first global approval.

Belinostat: first global approval.

Journal: Drugs

Published: August 20, 2014

Daclatasvir + asunaprevir: first global approval.

Daclatasvir + asunaprevir: first global approval.

Journal: Drugs

Published: August 14, 2014

Nemonoxacin: first global approval.

Nemonoxacin: first global approval.

Journal: Drugs

Published: August 01, 2014

Vedolizumab: first global approval.

Vedolizumab: first global approval.

Journal: Drugs

Published: July 03, 2014

Vorapaxar: first global approval.

Vorapaxar: first global approval.

Journal: Drugs

Published: June 26, 2014

Ramucirumab: first global approval.

Ramucirumab: first global approval.

Journal: Drugs

Published: June 12, 2014

Albiglutide: first global approval.

Albiglutide: first global approval.

Journal: Drugs

Published: May 28, 2014

Tofogliflozin: first global approval.

Tofogliflozin: first global approval.

Journal: Drugs

Published: May 23, 2014

Apremilast: first global approval.

Apremilast: first global approval.

Journal: Drugs

Published: May 07, 2014

Ipragliflozin: first global approval.

Ipragliflozin: first global approval.

Journal: Drugs

Published: March 27, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026